Furthermore, it was found that elevated SLC7A11 expression in cancer cells drives selenocysteine biosynthesis by promoting selenite reduction and uptake as an early step in selenocysteine biosynthesis [4]. This evidence concerns the gene SLC7A11 and cancer.